Cuartero CT, Lambert JW, Cuomo-Dannenburg G, Fitzner J, Ndumbi P, Rice C, Saulo D, Waddell L, Azam JM, Doohan P, Hicks JT, McCain K, Morgenstern C, Naidoo TM, Ruybul-Pesántez S, Rawson T, Santoni C, Unwin HJT, , Kucharski A, Cori A, Bhatia S, McCabe R. (2026). The impact of ambiguously reported epidemiological parameters for infectious disease modelling and recommended best practices. Epidemics
Aheto JMK, Auzenbergs M, Ferrari MJ, Portnoy A, Utazi CE, Kakaï RG, Gayawan E, Azam JM, Nonvignon J. (2026). Rebalancing power in infectious disease modelling: Toward inclusive and contextual approaches. PLOS global public health, 6(4)
van Zandvoort K, Procter SR, Azam JM, Sherratt K, Davies NG. (2026). The risk of global Ebola virus spread is low: epidemiology of Ebola disease cases outside Africa, 1976 to May 2026. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 31(24)
Ward J, Lambert JW, Russell TW, Azam JM, Kucharski AJ, Funk S, Quilty BJ, Gressani O, Hens N, Edmunds WJ. (2025). Estimates of epidemiological parameters for H5N1 influenza in humans: a rapid review. BMC infectious diseases, 25(1)
Azam JM, Pang X, Are EB, Pulliam JRC, Ferrari MJ. (2023). Modelling outbreak response impact in human vaccine-preventable diseases: A systematic review of differences in practices between collaboration types before COVID-19. Epidemics, (45)
Azam JM, Are EB, Pang X, Ferrari MJ, Pulliam JRC. (2020). Outbreak response intervention models of vaccine-preventable diseases in humans and foot-and-mouth disease in livestock: a protocol for a systematic review. BMJ open, 10(10)
If you’d like to update your profile, please email modifications to questions@midasnetwork.us.